Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) View the PDF document
Table of Contents
View the documentExecutive summary
View the documentI. Introduction
Open this folder and view contentsII. Background on the research project
Open this folder and view contentsIII. Second workshop
Open this folder and view contentsIV. Preliminary findings
Close this folderV. Conclusions of the workshop and follow-up plans
View the document1. Main outcomes
View the document2. Next steps
Open this folder and view contentsAnnex 1: Research proposal
View the documentAnnex 2: List of participants
View the documentAnnex 3: Agenda
View the documentAnnex 4: Questionnaire on NDP performance assessment
Open this folder and view contentsAnnex 5: Achievements of the national drug policies in the 12 countries
View the documentAnnex 6: Consolidated tables
View the documentOther documents in the DAP Research Series
 

2. Next steps

In order to finalize the research and to achieve the total expected outcomes, there are still a number of steps which need to be carried out in the months to come. These are:

• Improvement of the Excel programme DAP has prepared for processing and calculating the data for forwarding to the countries (July 1996).

• Finalization of the research at national level (data and reports), to be achieved by mid-September 1996.

• Comments from the three coordinating institutions on reports and data (end of October 1996).

• National workshops to disseminate the results and test hypotheses (end of February 1997).

• Writing of scientific articles and reports by the national teams for inclusion in a larger publication (end of April 1997).

• Organization of an international workshop in one of the countries involved (India has already proposed to host this). Its objectives will be: to review the hypotheses on policy process; to identify specific policy innovations from the cross-national approach that could improve the design and the implementation of pharmaceutical policy; and to propose ways to improve the political feasibility of implementing those innovations within specific political contexts.

• Preparation, editing, publishing and dissemination of the results through various publications.

Funding will be sought by DAP and IHCAR to carry out all these activities. If funding is not available, a contingency plan will be made at a later stage.

A number of countries have done the political mapping; for the time being, there are no funds to do this exercise in new countries but people are welcome to contact Michael Reich for advice by e-mail. It is also possible that students from Harvard or people from the region, who are already trained in the methodology, can assist countries in the political mapping.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014